Seeking Alpha
What is your profession? ×
Long/short equity, insider ownership
Profile| Send Message|
( followers)


6 insiders sold PerkinElmer stock within one month.

The stock was not purchased by any insiders in the month of intensive selling.

5 of these 6 insiders decreased their holdings by more than 10%.

PerkinElmer (NYSE:PKI) provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide.

(click to enlarge)

Insider selling during the last 30 days

Here is a table of PerkinElmer's insider activity during the last 30 days.

NameTitleTrade DateShares SoldOption Exercise & SaleRule 10b5-1Current OwnershipDecrease In Ownership
James CorbettSVPJune 1957,126YesYes21,858 shares + 6,262 options67.0%
Robert FrielCEOJune 5-9249,715YesYes532,310
shares + 1,026,135
Maurice TenneySVPJune 95,504YesYes28,999 shares + 18,979 options10.3%
Patrick SullivanDirectorJune 510,000YesNo27,294
shares + 36,561 options
Alexis MichasDirectorJune 2-515,000NoNo81,821 shares + 49,512
Joel GoldbergSVPJune 217,000NoYes50,859
shares + 157,324 options

There have been 354,345 shares sold by insiders during the last 30 days. James Corbett, Robert Friel, Maurice Tenney, and Joel Goldberg sold their shares pursuant to a Rule 10b5-1 plan. More details about the Rule 10b5-1 trading plan can be found from this link.

Insider selling by calendar month

Here is a table of PerkinElmer's insider activity by calendar month.

MonthInsider selling / sharesInsider buying / shares
June 2014354,3450
May 20145,5020
April 201480,3290
March 201474,6900
February 201454,7940
January 201400
December 201337,1830
November 2013112,4610
October 201300
September 2013147,8050
August 201316,0000
July 201300
June 201300
May 201312,8800
April 201326,3800
March 201328,2150
February 201300
January 201317,1790

There have been 967,763 shares sold and there have been zero shares purchased by insiders since January 2013. The month of June 2014 has seen the most insider selling.


PerkinElmer reported the first-quarter financial results on April 24 with the following highlights:

Revenue$531.9 million
Net income$34.2 million
Cash$224.1 million
Debt$929.5 million

The six insiders sold their shares after these results.


PerkinElmer's guidance is as follows:

GAAP EPS$0.45-$0.47$1.91-$1.95
Non-GAAP EPS$0.57-$0.59$2.42-$2.46


PerkinElmer's competitors include Agilent Technologies (NYSE:A), Thermo Fisher Scientific (NYSE:TMO), and Waters (NYSE:WAT). Here is a table comparing these companies.

Market Cap:5.33B19.59B47.45B8.99B
Qtrly Rev Growth (yoy):0.05-
Gross Margin:0.450.520.430.58
Operating Margin:
Net Income:169.95M713.00M1.48B399.25M
PEG (5 yr expected):1.972.081.372.14

PerkinElmer has the highest P/E ratio among these four companies.

Here is a table of these competitors' insider activities this year.

CompanyInsider buying / sharesInsider selling / shares

Only PerkinElmer has seen intensive insider selling during the last 30 days.


There have been six different insiders selling PerkinElmer and there have not been any insiders buying PerkinElmer during the last 30 days. Five of these six insiders decreased their holdings by more than 10%. PerkinElmer has an insider ownership of 0.96%.

Before going short PerkinElmer, I would like to get a bearish confirmation from the Point & Figure chart. The two main reasons for the proposed short entry are a relatively high P/E ratio, and the intensive insider-selling activity.

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.